
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.
Journal: BJU international
Published: July 02, 2026
Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: March 06, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio.
Journal: Urologic oncology
Published: October 31, 2025
EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer.
Journal: The oncologist
Published: October 11, 2025
Patterns of local therapy following enfortumab vedotin in advanced urothelial carcinoma.
Journal: Urologic oncology
Published: August 01, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Journal: The oncologist
Published: June 09, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy.
Journal: Clinical genitourinary cancer
Published: May 13, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Journal: European urology
Published: May 07, 2025
Gender Disparities in Citations and Altmetric Attention Score in Oncology.
Journal: JCO oncology practice
Published: April 10, 2025
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function.
Journal: BJU international
Published: December 10, 2024
Last Updated: 09/26/2026